MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)
Status:
Completed
Trial end date:
2010-08-11
Target enrollment:
Participant gender:
Summary
The phase III clinical trial examines the efficacy, safety, and tolerability of the addition
of MK0431/ONO-5435 to Japanese patients with type 2 diabetes mellitus (T2DM) who have
inadequate glycemic control on diet/exercise therapy and voglibose monotherapy